and/or its affiliates. All rights reserved. A WarnerMedia Company. "We won't see drugs with the longevity of Lipitor," Kaitin says. cardiovascular, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. "The patients are the winners here," said Bob Billings, executive director of the Generic Pharmaceutical Association.The cholesterol-cutting drug has long served as the top earner for Pfizer (There are 3 million Americans currently taking the drug, according to Pfizer, and all of them stand to save significant amounts of money. Research and development (R&D) budgets soared, but the rate at which new drugs were approved did not. Pfizer bought out Warner-Lambert in 2000 to block two other companies trying to acquire it and get control of Lipitor. But by the end of 2010, that investment would have shrunk to $20. Disclaimer. Therefore, the patient is paying $60 for the brand name Concerta rather than $10 for the generic. All rights reserved.

© 2020 Once Ranbaxy's 180-day exclusivity expires, other generic drugmakers such as Mylan Inc. (Ranbaxy's exclusivity fell into murky territory earlier this year, when the A Ranbaxy representative did not immediately return a message from CNNMoney about how the FDA's accusations might affect its production of atorvastatin. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 Most stock quote data provided by BATS. "The industry is truly in crisis mode," says Ken Kaitin, director of the Tufts Center for the Study of Drug Development in Boston, Massachusetts. Cable News Network. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Lipitor owed its success in part to working better than other drugs, with few side effects, in a class where demand for effective therapies is high. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Pharmaceutical industry anxiously struggles to retool as Lipitor patent expires. "And The Beatles were being given out for free while you had to sell yours at full price. No wonder, then, that some generics companies posted high double-digit growth rates last year. The Indian drug maker Ranbaxy won the legal battle to own exclusive independent production rights to produce generic atorvastatin.

and/or its affiliates. All rights reserved. A WarnerMedia Company. "We won't see drugs with the longevity of Lipitor," Kaitin says. cardiovascular, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. "The patients are the winners here," said Bob Billings, executive director of the Generic Pharmaceutical Association.The cholesterol-cutting drug has long served as the top earner for Pfizer (There are 3 million Americans currently taking the drug, according to Pfizer, and all of them stand to save significant amounts of money. Research and development (R&D) budgets soared, but the rate at which new drugs were approved did not. Pfizer bought out Warner-Lambert in 2000 to block two other companies trying to acquire it and get control of Lipitor. But by the end of 2010, that investment would have shrunk to $20. Disclaimer. Therefore, the patient is paying $60 for the brand name Concerta rather than $10 for the generic. All rights reserved.

© 2020 Once Ranbaxy's 180-day exclusivity expires, other generic drugmakers such as Mylan Inc. (Ranbaxy's exclusivity fell into murky territory earlier this year, when the A Ranbaxy representative did not immediately return a message from CNNMoney about how the FDA's accusations might affect its production of atorvastatin. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 Most stock quote data provided by BATS. "The industry is truly in crisis mode," says Ken Kaitin, director of the Tufts Center for the Study of Drug Development in Boston, Massachusetts. Cable News Network. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Lipitor owed its success in part to working better than other drugs, with few side effects, in a class where demand for effective therapies is high. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Pharmaceutical industry anxiously struggles to retool as Lipitor patent expires. "And The Beatles were being given out for free while you had to sell yours at full price. No wonder, then, that some generics companies posted high double-digit growth rates last year. The Indian drug maker Ranbaxy won the legal battle to own exclusive independent production rights to produce generic atorvastatin.

and/or its affiliates. All rights reserved. A WarnerMedia Company. "We won't see drugs with the longevity of Lipitor," Kaitin says. cardiovascular, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. "The patients are the winners here," said Bob Billings, executive director of the Generic Pharmaceutical Association.The cholesterol-cutting drug has long served as the top earner for Pfizer (There are 3 million Americans currently taking the drug, according to Pfizer, and all of them stand to save significant amounts of money. Research and development (R&D) budgets soared, but the rate at which new drugs were approved did not. Pfizer bought out Warner-Lambert in 2000 to block two other companies trying to acquire it and get control of Lipitor. But by the end of 2010, that investment would have shrunk to $20. Disclaimer. Therefore, the patient is paying $60 for the brand name Concerta rather than $10 for the generic. All rights reserved.

© 2020 Once Ranbaxy's 180-day exclusivity expires, other generic drugmakers such as Mylan Inc. (Ranbaxy's exclusivity fell into murky territory earlier this year, when the A Ranbaxy representative did not immediately return a message from CNNMoney about how the FDA's accusations might affect its production of atorvastatin. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 Most stock quote data provided by BATS. "The industry is truly in crisis mode," says Ken Kaitin, director of the Tufts Center for the Study of Drug Development in Boston, Massachusetts. Cable News Network. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Lipitor owed its success in part to working better than other drugs, with few side effects, in a class where demand for effective therapies is high. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Pharmaceutical industry anxiously struggles to retool as Lipitor patent expires. "And The Beatles were being given out for free while you had to sell yours at full price. No wonder, then, that some generics companies posted high double-digit growth rates last year. The Indian drug maker Ranbaxy won the legal battle to own exclusive independent production rights to produce generic atorvastatin.